Search Results - "Buell, Jamie"

Response of an ERBB2-mutated inflammatory breast carcinoma to human epidermal growth factor receptor 2-targeted therapy by Ali, Siraj M, Alpaugh, R Katherine, Downing, Sean R, Stephens, Philip J, Yu, Jian Q, Wu, Hong, Buell, Jamie K, Miller, Vincent A, Lipson, Doron, Palmer, Gary A, Ross, Jeffrey S, Cristofanilli, Massimo

Get full text

Antitumor Response of an ERBB2 Amplified Inflammatory Breast Carcinoma With EGFR Mutation to the EGFR-TKI Erlotinib by Ali, Siraj M, Alpaugh, R. Kathy, Buell, Jamie K, Stephens, Philip J, Yu, Jian Qin (Michael), Wu, Hong, Hiemstra, Christine N, Miller, Vincent A, Lipson, Doron, Palmer, Gary A, Ross, Jeffrey S, Cristofanilli, Massimo

Get full text

Development of a PD-L1 multiplex immunofluorescence assay with advanced visual analysis for understanding the tumor microenvironment by Downing, Sean, Sharma, Aditi, Hebert, Courtney, Buell, Jamie, Wood, Douglas

“…Abstract only e14283 Background: Current PD-L1 Immunohistochemistry (IHC) assays utilizing conventional brightfield, chromogenic 3,3′-Diaminobenzidine (DAB)…”
Get full text

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing by Frampton, Garrett M, Fichtenholtz, Alex, Otto, Geoff A, Wang, Kai, Downing, Sean R, He, Jie, Schnall-Levin, Michael, White, Jared, Sanford, Eric M, An, Peter, Sun, James, Juhn, Frank, Brennan, Kristina, Iwanik, Kiel, Maillet, Ashley, Buell, Jamie, White, Emily, Zhao, Mandy, Balasubramanian, Sohail, Terzic, Selmira, Richards, Tina, Banning, Vera, Garcia, Lazaro, Mahoney, Kristen, Zwirko, Zac, Donahue, Amy, Beltran, Himisha, Mosquera, Juan Miguel, Rubin, Mark A, Dogan, Snjezana, Hedvat, Cyrus V, Berger, Michael F, Pusztai, Lajos, Lechner, Matthias, Boshoff, Chris, Jarosz, Mirna, Vietz, Christine, Parker, Alex, Miller, Vincent A, Ross, Jeffrey S, Curran, John, Cronin, Maureen T, Stephens, Philip J, Lipson, Doron, Yelensky, Roman

“…Clinical tests that rely on next-generation sequencing to evaluate large numbers of cancer genes can be validated using pooled cell lines with known mutations…”
Get full text

Abstract 5657: Use of a novel immunofluorescence multiplexing technology, InSituPlex™, for the simultaneous detection of immune cells in multiple cancer types by Downing, Sean, Patel, Katir, Buell, Jamie, Hebert, Courtney

“…Abstract Introduction: The field of immuno-oncology has enthusiastically adopted multiplexed immunohistochemistry (IHC) techniques to establish the spatial…”
Get full text

Abstract 5652: Validation of novel InSituPlex™ technology utilizing standard chromogenic IHC and multiplexed tyramide-based immunofluorescence by Patel, Katir, Hebert, Courtney, Buell, Jamie, Downing, Sean

“…Abstract Introduction: The demands of today's immuno-oncology research has driven the development of more robust tools to interrogate the tumor…”
Get full text

Abstract LB-275: Measuring concordance of CD8 and PD-L1 expression in non-small cell lung cancer between a novel multiplex immunofluorescence assay and a brightfield laboratory developed test by Shitole, Shravani, Johnson, Monique, Hebert, Courtney, Buell, Jamie, Ly, Amy, Downing, Sean R.

“…Abstract The quantitative assessment of PD-L1 protein expression has been widely used in the clinic to predict response to immune checkpoint therapy in…”
Get full text

Abstract 1677: Understanding the TME: Advanced analysis and visualization of multiplexed fluorescence images by Wood, Douglas, Phillips, Bonnie, Hebert, Courtney, Sharma, Aditi, Buell, Jamie, Downing, Sean

“…Abstract Background: Multiplexed immunofluorescence (mIF) has the potential to revolutionize immuno-oncology and pathology research as it enables the…”
Get full text

Abstract 4569: Intra- and inter-run assessment of reproducibility and quantification of UltiMapper™ I/O APC and T-act kits for tissue multiplexing by Phillips, Bonnie, Patel, Katir, Hebert, Courtney, Sharma, Aditi, Buell, Jamie, Downing, Sean

“…Abstract Background: The field of immuno-oncology research has enthusiastically adopted multiplex immunohistochemistry (IHC) techniques to establish the…”
Get full text

Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations by Ali, Siraj M., Pal, Sumanta K., Wang, Kai, Palma, Norma A., Sanford, Eric, Bailey, Mark, He, Jie, Elvin, Julia A., Chmielecki, Juliann, Squillace, Rachel, Dow, Edward, Morosini, Deborah, Buell, Jamie, Yelensky, Roman, Lipson, Doron, Frampton, Garrett M., Howley, Peter, Ross, Jeffrey S., Stephens, Philip J., Miller, Vincent A.

“…Background. Advanced penile squamous cell carcinoma (PSCC) is associated with poor survival due to the aggressiveness of the disease and lack of effective…”
Get full text